Bandingkan Harga & Kinerja Sentral Mitra Informatika Tbk. (LUCK) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Sentral Mitra Informatika Tbk. dan Organon Pharma Indonesia Tbk.: Sentral Mitra Informatika Tbk. diperdagangkan di Rp117 (kapitalisasi pasar 85,17 M, volume 24 jam 982,9 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Organon Pharma Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| LUCK | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 85,17 M | 104,4 M |
Volume | 982,9 rb | — |
Lot | 9,83 rb | — |
Perputaran | 114,55 jt | — |
Harga Rata-rata | 116,55 | — |
Nilai Transaksi | 114,55 jt | — |
Harga Ekuilibrium Indikatif | 116 | — |
Volume Ekuilibrium Indikatif | 183 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Sentral Mitra Informatika Tbk.
PT Sentral Mitra Informatika Tbk (the Company), was established in the Republic of Indonesia under the framework of the Domestic Capital Investment Law No. 6 year 1968 based on notarial Deed No. 11 dated November 14, 2008 of Henny Hendrawati Putradjaja, S.H., Notary in Jakarta.
Selengkapnya di halaman LUCK →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
